Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

GoodRx Stock Tumbles Over 40% After Pulling Guidance, Analyst Blames Kroger For the Slump

Published 05/10/2022, 03:02 AM
Updated 05/10/2022, 07:34 AM
© Reuters.  GoodRx (GDRX) Stock Tumbles Over 40% After Pulling Guidance, Analyst Blames Kroger (KR) For the Slump
KR
-
GDRX
-

Shares of GoodRx Holdings (NASDAQ:GDRX) are down more than 40% in premarket trading Tuesday after the company withdrew its FY 2022 outlook.

GoodRx reported Q1 adjusted EPS of 10c, beating the consensus estimates of 8c per share. Total revenue in the first quarter came in at $203.3 million, up 27% YoY and above the analyst expectations of $200.4 million.

For Q2, GDRX expects $190 million in revenue, well below the consensus estimates of $216.1 million. The company said it will not provide FY guidance at this time.

GoodRx also said it saw a major grocery chain take steps that affected the acceptance of discounts from most pharmacy benefit managers (PBMs) for a subset of drugs. The issue left a direct impact on the company’s consumers as the majority of discounts on GoodRx products are provided by PBMs.

As a result, GoodRx saw a sharp decline in volume and expects an even stronger impact on its Q2 and FY performance.

At least 4 analysts downgraded GDRX stock after earnings. Evercore ISI analyst Mark Mahaney moved to In Line from Outperform with a $12.00 per share price target, down from $28.00.

“While [the PBMs] decision may get reversed, the revenue concentration risk was a negative surprise to us and followed last quarter’s warning that depressed new prescription starts would negatively impact GDRX’s Prescription Transaction Revenue segment (75%+ of revenue). All in, we have significantly less visibility into – and confidence in -- GDRX’s topline trends,” Mahaney said in a client note.

Raymond James analyst John Ransom also downgraded to Market Perform from Outperform, citing the same reason. While GDRX didn’t mention which grocer stopped accepting GoodRx discounting cards, Ransom said that checks show it is Kroger (NYSE:KR).

“One PBM tells us that Kroger is directing traffic away from the GDRX discount card to other discount programs, including its own card. We have heard several theories as to why Kroger is taking this course of action, but need to do more legwork to confirm. At any rate, we think the risk that KR remains out of GDRX’s network is real. While the company may, indeed be able to keep its retail network intact and offset some damage, we think that the PTR customer base is smaller than it otherwise would have been, maybe permanently and that the stock will remain in the penalty box until visibility improves,” Ransom wrote to clients.

By Senad Karaahmetovic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.